BlackRock Advisors LLC cut its stake in Halyard Health Inc. (NYSE:HYH) by 2.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 515,913 shares of the company’s stock after selling 15,363 shares during the period. BlackRock Advisors LLC owned approximately 1.10% of Halyard Health worth $16,778,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also recently modified their holdings of HYH. Tower Research Capital LLC TRC bought a new position in Halyard Health during the second quarter valued at approximately $104,000. LS Investment Advisors LLC increased its position in Halyard Health by 25.6% in the second quarter. LS Investment Advisors LLC now owns 3,241 shares of the company’s stock valued at $105,000 after buying an additional 661 shares during the period. Acrospire Investment Management LLC bought a new position in Halyard Health during the second quarter valued at approximately $190,000. Springbok Capital Management LLC increased its position in Halyard Health by 151.9% in the first quarter. Springbok Capital Management LLC now owns 6,800 shares of the company’s stock valued at $195,000 after buying an additional 4,100 shares during the period. Finally, Teacher Retirement System of Texas increased its position in Halyard Health by 9.0% in the second quarter. Teacher Retirement System of Texas now owns 6,512 shares of the company’s stock valued at $212,000 after buying an additional 535 shares during the period. 82.94% of the stock is owned by institutional investors.
Halyard Health Inc. (NYSE:HYH) opened at 34.54 on Thursday. Halyard Health Inc. has a one year low of $22.76 and a one year high of $37.31. The company has a 50 day moving average of $35.62 and a 200-day moving average of $32.38. The company’s market cap is $1.61 billion.
Halyard Health (NYSE:HYH) last released its quarterly earnings data on Wednesday, August 3rd. The company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.36 by $0.09. Halyard Health had a negative net margin of 27.63% and a positive return on equity of 8.91%. The company earned $400 million during the quarter, compared to analysts’ expectations of $383.08 million. During the same quarter in the previous year, the company earned $0.52 earnings per share. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. On average, equities analysts expect that Halyard Health Inc. will post $1.82 earnings per share for the current fiscal year.
HYH has been the subject of several research reports. Deutsche Bank AG increased their price objective on shares of Halyard Health from $36.00 to $41.00 and gave the company a “buy” rating in a report on Wednesday, August 10th. Stifel Nicolaus increased their price objective on shares of Halyard Health from $32.00 to $37.00 and gave the company a “buy” rating in a report on Tuesday, June 14th. Finally, TheStreet raised shares of Halyard Health from a “sell” rating to a “hold” rating in a report on Friday, July 8th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and five have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $34.20.
About Halyard Health
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.